Thoracic malignancies represent the leading cause of cancer death in the United States. This continuing medical education activity will focus on recent developments in medical, surgical, radiation and medical oncologic care of patients with malignancies of the chest. The conference will emphasize recent developments in molecular pathways of carcinogenesis and immunobiology as well as novel surgical and interventional techniques. Important clinical advances and clinical trials including surgical, medical, radiation and palliative management will be presented by a distinguished faculty.
Upon conclusion of this program, participants should be able to:
- Select appropriate patients for lung cancer screening.
- Evaluate the benefit for minimally invasive over open thoracic surgery.
- Recognize the role of particle beam radiation in thoracic malignancy.
- Demonstrate knowledge of the role of immunotherapy in thoracic cancers.
12.50 AMA PRA Category 1 Credit™ - maximum
Mayo Clinic Hospital Education Center
November 9-10, 2018
Phoenix, Arizona 85054, United States